Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boeing
BA
|
+$830M |
| 2 |
UnitedHealth
UNH
|
+$769M |
| 3 |
Arthur J. Gallagher & Co
AJG
|
+$691M |
| 4 |
Amazon
AMZN
|
+$654M |
| 5 |
Bank of America
BAC
|
+$634M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.23B |
| 2 |
NVIDIA
NVDA
|
+$550M |
| 3 |
Spotify
SPOT
|
+$473M |
| 4 |
Citigroup
C
|
+$460M |
| 5 |
Boston Scientific
BSX
|
+$428M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 3.13% |
| 2 | Technology | 2.97% |
| 3 | Financials | 2.19% |
| 4 | Consumer Discretionary | 2.09% |
| 5 | Industrials | 1.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3301
PUT
Harrow
HROW
$1.5B
| $7.58M | ﹤0.01% |
225,900
+26,700
| +13% | +$1.18M |
|
3302
Avantor
AVTR
$9.24B
| $7.57M | ﹤0.01% |
359,068
-1,258,089
| -78% | -$28.3M |
|
3303
CALL
BWX Technologies
BWXT
$15.9B
| $7.56M | ﹤0.01% |
67,900
+27,200
| +67% | +$3.32M |
|
|
HOLX
3304
PUT
DELISTED
Hologic
HOLX
| $7.56M | ﹤0.01% |
104,900
+63,700
| +155% | +$4.98M |
|
|
TIGR
3305
CALL
UP Fintech Holding
TIGR
$822M
| $7.55M | ﹤0.01% |
1,169,300
+499,800
| +75% | +$3.44M |
|
3306
CALL
Universal Health Services
UHS
$10B
| $7.55M | ﹤0.01% |
42,100
+14,900
| +55% | +$3.03M |
|
3307
PUT
Alamos Gold
AGI
$14B
| $7.55M | ﹤0.01% |
409,500
-124,200
| -23% | -$2.4M |
|
3308
iShares Agency Bond ETF
AGZ
$565M
| $7.55M | ﹤0.01% |
69,910
+67,502
| +2,803% | +$7.34M |
|
|
DESP
3309
DELISTED
Despegar.com
DESP
| $7.54M | ﹤0.01% |
391,927
+144,946
| +59% | +$2.28M |
|
3310
CALL
Pan American Silver
PAAS
$19.7B
| $7.53M | ﹤0.01% |
372,620
-274,500
| -42% | -$6.14M |
|
3311
Boise Cascade
BCC
$2.9B
| $7.53M | ﹤0.01% |
63,373
-39,541
| -38% | -$5.46M |
|
3312
BioLife Solutions
BLFS
$1.72B
| $7.52M | ﹤0.01% |
289,586
+24,089
| +9% | +$599K |
|
3313
PUT
Aurora
AUR
$13.7B
| $7.51M | ﹤0.01% |
1,191,900
+520,800
| +78% | +$3.26M |
|
3314
Nordic American Tanker
NAT
$1.42B
| $7.5M | ﹤0.01% |
3,001,870
+3,001,376
| +607,566% | +$9.22M |
|
3315
CALL
Freshpet
FRPT
$3.5B
| $7.49M | ﹤0.01% |
50,600
+6,300
| +14% | +$918K |
|
3316
PUT
Polaris
PII
$3.95B
| $7.49M | ﹤0.01% |
130,000
+101,800
| +361% | +$7.08M |
|
|
CMA
3317
CALL
DELISTED
Comerica
CMA
| $7.49M | ﹤0.01% |
121,100
-43,600
| -26% | -$2.83M |
|
3318
Turning Point Brands
TPB
$1.75B
| $7.49M | ﹤0.01% |
124,579
+46,881
| +60% | +$2.5M |
|
3319
PUT
Main Street Capital
MAIN
$5.5B
| $7.47M | ﹤0.01% |
127,600
+63,100
| +98% | +$3.36M |
|
3320
AngioDynamics
ANGO
$655M
| $7.47M | ﹤0.01% |
815,826
+632,376
| +345% | +$4.65M |
|
3321
iShares 0-1 Year Treasury Bond ETF
SHV
$20.6B
| $7.45M | ﹤0.01% |
67,689
-114,457
| -63% | -$12.6M |
|
3322
Amylyx Pharmaceuticals
AMLX
$2.41B
| $7.45M | ﹤0.01% |
1,970,704
+71,144
| +4% | +$335K |
|
|
AIOT
3323
PowerFleet Inc
AIOT
$417M
| $7.45M | ﹤0.01% |
1,118,180
-2,367,229
| -68% | -$14.2M |
|
3324
PUT
Star Bulk Carriers
SBLK
$3.24B
| $7.44M | ﹤0.01% |
497,900
+296,300
| +147% | +$5.51M |
|
3325
PUT
West Pharmaceutical
WST
$24.6B
| $7.44M | ﹤0.01% |
22,700
-21,800
| -49% | -$6.86M |
|
Similar funds
Ken Griffin's Q4 2024 Portfolio in Review
As of Q4 2024, Ken Griffin held 15,826 positions worth $578B, up 11% from $518B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Ken Griffin deployed $35.2B of net new capital in Q4 2024, opening 1,745 new positions and adding to 6,428 existing holdings. Its largest new stake was Zoetis: 1,090,499 shares worth $178M.
By sector, the portfolio is most concentrated in Healthcare at 3.1% of assets, up from 2.9% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $1.23B trimmed.
- Ken Griffin's largest Q4 2024 buy was Zoetis: 1,090,499 shares worth $178M.
- Ken Griffin added most to Boeing in Q4 2024, an estimated $830M increase.
- Ken Griffin's biggest Q4 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.23B.
- Ken Griffin fully exited Spotify in Q4 2024, selling an estimated $473M.
- Ken Griffin's ten largest holdings make up 31% of its $578B portfolio in Q4 2024.
- Ken Griffin opened 1,745 new positions and closed 1,423 in Q4 2024.
- Ken Griffin's portfolio value rose 11% quarter-over-quarter to $578B.
Based on Citadel Advisors's 13F filing for Q4 2024, filed 14 Feb 2025.